Plasma small-extracellular vesicles’ proteomic signature in neoadjuvant chemotherapy–naïve breast cancer patients
PLOS One · 2026
DOI: 10.1371/journal.pone.0348500 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Amr Ahmed WalyEldeen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt. Hauptthemen laut MEDLINE: Breast Neoplasms, Proteomics, Extracellular Vesicles, Proteome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science, Technology, & Innovation Funding Authority.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Breast cancer remains a leading cause of cancer-related mortality worldwide, with obesity markedly increasing the risk in affected individuals. Liquid biopsy-based extracellular vesicles (EVs) offer a minimally invasive platform for molecular profiling of tumor-derived markers. Plasma small-EVs from obese, chemotherapy-naïve breast cancer patients (n = 76; stages I–III) and age-matched obese controls (n = 36) were enriched and characterized by high-resolution transmission electron microscopy, dynamic light scattering (DLS) and specific EV markers. Proteomic profile of the enriched small-EVs using nanoLC-MS/MS identified Fibronectin 1 (FN1) and von Willebrand Factor (VWF) as candidate markers. Bioinformatics and STRING networks revealed interactions with Syndecan-2 (SDC2) and Galectin-3 (Gal-3). As an independent validation, western blot confirmed that FN1, VWF, and SDC2 were higher enriched in the small-EVs of breast cancer with different stages than in those of normal and that high content of small-EVs FN1 and SDC2 was primarily associated with the aggressive triple-negative breast cancer (TNBC) subtype. Interestingly, Gal-3 was reduced in small-EVs but elevated in breast carcinoma tissues and microvesicle (MV)-enriched EVs. Functionally, treatment with TNBC-derived plasma small-EVs not only downregulated expression of epithelial marker CDH1, and upregulated expression of the mesenchymal markers ZEB2 and FN1 in low-invasive MCF-7 breast cancer cells, but also elevated expression of inflammatory and matrix-remodeling mediators ( Il-6 , Tnf-α , and Mmp-9 ) in BNL CL.2 normal liver cells. ROC-Plotter and drug–gene interaction analyses indicated associations with therapy response, with approved compounds targeting FN1 and VWF. Overall, these findings reveal proteomic signatures of minimally invasive plasma small-EVs as promising markers associated with diagnosis, molecular subtyping, disease progression, and guiding therapeutic strategies in obese breast cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt.
- Department of Pathology, National Cancer Institute, Cairo University, Cairo, Egypt.
- Department of Surgical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt.
- Department of Surgical Oncology, Baheya Centre for Early Detection and Treatment of Breast Cancer, Giza, Egypt.
- Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
ORCID-Profile: Sherif Abdelaziz Ibrahim
Förderung
- Science, Technology, & Innovation Funding Authority
Zitieren
APA
WalyEldeen, A. A., Mohamed, G., Taha, S. N., Gameel, A. M., Talat, L. Y., Hassan, H., & Ibrahim, S. A. (2026). Plasma small-extracellular vesicles’ proteomic signature in neoadjuvant chemotherapy–naïve breast cancer patients. PLOS One. https://doi.org/10.1371/journal.pone.0348500
Vancouver
WalyEldeen AA, Mohamed G, Taha SN, Gameel AM, Talat LY, Hassan H, et al. Plasma small-extracellular vesicles’ proteomic signature in neoadjuvant chemotherapy–naïve breast cancer patients. PLOS One. 2026. doi:10.1371/journal.pone.0348500
BibTeX
@article{WalyEldeen2026,
author = {WalyEldeen, Amr Ahmed and Mohamed, Ghada and Taha, Sherif Nasser and Gameel, Abdallah M and Talat, Liali Yousef and Hassan, Hebatallah and Ibrahim, Sherif Abdelaziz},
title = {Plasma small-extracellular vesicles’ proteomic signature in neoadjuvant chemotherapy–naïve breast cancer patients},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0348500}
}
EUVIMED